Year8
In 2008, President Clinton, then President of the United States, announced that the draft human genome sequence had been completed. Since then, researchers' research on certain types of cancer has increased exponentially. Chemistry Research Report: Drug treatments for cancer and chronic myelogenous leukemia (CML) have been studied for many years: the discovery of the human genome has promoted the rapid development of cancer treatments. Researchers confirmed that, as originally reported by researchers at Novartis (r) and Oregon Health & Science University (), Gleevec (), a first-generation drug targeting chronic myelogenous leukemia (), has Be successful. Second- and third-generation targeted drugs for chronic myeloid leukemia (CML) have benefited from the successful patent application of Gleevec () and continue to drive the growth of research work and patent publications in chronic myelogenous leukemia (CML). .
According to the report, in the past year, the number of journal publications on cancer treatment has increased by 20%, while the number of patent publications has increased by 20%. %. At the same time, the number of patent publications has exploded by %. The World Intellectual Property Organization (Z,) is the primary patent agency for Gleevec (), a treatment for chronic myelogenous leukemia (CML). American researchers publish three times more Gleevec (Gleevec) journal articles than any other country. In 2016, the second-generation drugs nilotinib ( ) and dasatinib ( ) replaced Gleevec ( ) as single-agent treatments for chronic myelogenous leukemia ( ), with a combined number of journal publications and patent publications. The number is twice that of Gleevec ().
<&The analyst's conclusions in the chemical research report further confirm that its direction is correct**. The accelerated growth in the number of publications related to chronic myelogenous leukemia (CML) following the discovery of Gleevec (Gleevec) is further evidence that targeted approaches open up new avenues of medical and scientific exploration. On this basis, all cancers can be controlled by drugs such as Gleevec (Gleevec). & Dr. B, director of the Knight Cancer Institute at Oregon Health & Science University, said.
WhatsApp
